Suppr超能文献

杂环化合物作为碳酸酐酶抑制剂的化学:药物化学研究的新途径综述。

Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review.

机构信息

Department of Chemistry, Presidency University, Bengaluru, Karnataka, India.

Department of Chemistry, Faculty of Science, SGT University, Gurugram, Haryana, India.

出版信息

Arch Pharm (Weinheim). 2024 Jul;357(7):e2400073. doi: 10.1002/ardp.202400073. Epub 2024 Apr 29.

Abstract

Nowadays, the scientific community has focused on dealing with different kinds of diseases by exploring the chemistry of various heterocycles as novel drugs. In this connection, medicinal chemists identified carbonic anhydrases (CA) as one of the biologically active targets for curing various diseases. The widespread distribution of these enzymes and the high degree of homology shared by the different isoforms offer substantial challenges to discovering potential drugs. Medicinal and synthetic organic chemists have been continuously involved in developing CA inhibitors. This review explored the chemistry of different heterocycles as CA inhibitors using the last 11 years of published research work. It provides a pathway for young researchers to further explore the chemistry of a variety of synthetic as well as natural heterocycles as CA inhibitors.

摘要

如今,科学界专注于通过探索各种杂环化合物的化学性质来寻找治疗各种疾病的新型药物。在这方面,药物化学家将碳酸酐酶 (CA) 确定为治疗各种疾病的有生物活性的靶标之一。这些酶广泛分布,不同同工酶之间具有高度同源性,这给发现潜在药物带来了巨大挑战。药物和合成有机化学家一直在不断致力于开发碳酸酐酶抑制剂。本综述探讨了过去 11 年发表的研究工作中不同杂环化合物作为碳酸酐酶抑制剂的化学性质。它为年轻研究人员进一步探索各种合成和天然杂环化合物作为碳酸酐酶抑制剂的化学性质提供了途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验